Vagus Nerve Stimulation for Inflammation Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for treating inflammatory disorders through stimulation of the cholinergic anti-inflammatory pathway, such as the vagus nerve, often disrupt cardiac and respiratory functions, and there is a need for a more precise and controlled approach to inhibit pro-inflammatory cytokine production without affecting other biological systems.
Innovation Solution
The use of extremely low duty-cycle electrical stimulation of the vagus nerve with parameters like voltage between 0.01 Volt to 1 Volt, pulse width from 0.1 ms to 5 ms, frequency from 0.1 Hz to 30 Hz, and specific on-time and off-time intervals to inhibit inflammation while minimizing effects on heart rate and other cardiac parameters.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional electrical stimulation of the vagus nerve is used to treat inflammatory disorders, then pro-inflammatory cytokine production is inhibited, but cardiac and respiratory functions are disrupted
Solution Approach 1:
The patent applies local quality by using high-frequency stimulation (≥100 Hz) specifically targeted at the vagus nerve to activate the cholinergic anti-inflammatory pathway, while the extremely low duty cycle (0.1-10%) ensures that stimulation is localized in time and space, preventing widespread cardiac and respiratory disruption. This selective activation allows anti-inflammatory effects without systemic side effects.
Solution Approach 2:
The patent employs periodic action through extremely low duty cycle stimulation patterns, where brief stimulation bursts (0.1-10% of total time) are interspersed with longer rest periods. This periodic delivery allows the vagus nerve to be activated for anti-inflammatory purposes while sufficient rest intervals prevent cumulative effects that would disrupt cardiac and respiratory functions.
2Reliability
If higher intensity electrical stimulation is applied to ensure adequate inhibition of pro-inflammatory cytokines, then anti-inflammatory effect is enhanced, but side effects on other biological systems increase
Solution Approach 1:
The patent utilizes parameter changes by optimizing the frequency to ≥100 Hz and duty cycle to 0.1-10%, creating a specific stimulation regime that selectively activates the cholinergic anti-inflammatory pathway. This precise parameter selection ensures adequate inflammation inhibition while the low duty cycle inherently limits total energy delivery, reducing side effects on other biological systems.
Solution Approach 2:
The patent achieves continuity of useful action through repeated stimulation sessions that maintain suppression of pro-inflammatory cytokines over time. The extremely low duty cycle allows continuous treatment protocols without accumulating harmful effects, as each brief stimulation burst contributes to sustained anti-inflammatory action while rest periods prevent side effect accumulation.
3Reliability
If traditional vagus nerve stimulation parameters are used, then inflammatory response is suppressed, but precision and control over the stimulation effect are reduced
Solution Approach 1:
The patent applies dynamics by implementing adjustable stimulation parameters including frequency (≥100 Hz) and duty cycle (0.1-10%), allowing precise control over the stimulation effect. This dynamic parameter control enables clinicians to optimize treatment for individual patients and adjust based on response, achieving both reliable inflammation suppression and precise stimulation control.
Solution Approach 2:
The patent incorporates feedback mechanisms by monitoring inflammatory markers and adjusting stimulation parameters accordingly. This feedback loop allows precise control over the stimulation effect, ensuring adequate inflammation suppression while minimizing side effects through real-time parameter optimization based on patient response.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method effectively treats inflammatory disorders by significantly reducing pro-inflammatory cytokine production with milder electrical signals than previously used, offering a safer and more targeted approach that maintains normal cardiac and respiratory functions.
Implementation Method 1
the nervous system regulates systemic inflammation through an α7 nicotinic acetylcholine receptor (α7nAChR)-dependent vagus nerve pathway to the spleen, termed the cholinergic anti-inflammatory pathway
Implementation Method 2
Electrical stimulation of the anti-inflammatory pathway (e.g., the vagus nerve or other portions of the anti-inflammatory reflex such as the splenic nerve, the hepatic nerve, etc.) inhibits pro-inflammatory cytokine production
Data Source
AI summary
Described herein are methods for treating a subject suffering from or at risk for a condition mediated by an inflammatory cytokine cascade, by electrically or mechanically stimulating vagus nerve activity in an amount sufficient to inhibit the inflammatory cytokine cascade.